 HOUSTON, Texas and VANCOUVER, BC, March 26, 2021 PRNewswire - ESSA Pharma Inc. ESSA or the Company Nasdaq: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Ari Brettman, M.D., has stepped down from ESSAs Board of Directors, which he has been a member of since 2019. 